• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION VALVE CONTEGRA; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION VALVE CONTEGRA; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number CONTEGRA
Device Problem Calcified (1077)
Patient Problems Ossification (1428); Calcium Deposits/Calcification (1758); Pulmonary Valve Stenosis (2024)
Event Date 01/01/2005
Event Type  Injury  
Manufacturer Narrative
Citation: boethig d et al.Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and contegras.European journal of cardio-thoracic surgery.2005; (27) 58¿66.Doi:10.1016/j.Ejcts.2004.09.009.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding explants and reoperation rates between different devices used to reconstruct the right ventricular outflow tract (rvot).All data were collected from a single center between april 1991 and january 2003.The study population included 190 patients (predominantly female; mean age 4.3 years), 109 of which were implanted with a medtronic contegra conduit (serial numbers were not provided).Among all contegra patients, there was an observed hospital mortality rate of 7.4% (below the expected rate of 10.2%).None of the deaths were attributed to medtronic product.Among all patients observed adverse events included: pulmonary artery stenosis, ossification, calcification, and reoperations including explant of the conduit.No additional adverse patient effects or product performance issues were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALVE CONTEGRA
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key6584690
MDR Text Key75761406
Report Number2025587-2017-00846
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/25/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCONTEGRA
Device Catalogue NumberCONTEGRA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/25/2017
Initial Date FDA Received05/23/2017
Supplement Dates Manufacturer Received04/25/2017
Supplement Dates FDA Received10/04/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 MO
-
-